...
首页> 外文期刊>Sexually transmitted diseases >Molecular typing of Treponema pallidum strains in western Canada: predominance of 14d subtypes.
【24h】

Molecular typing of Treponema pallidum strains in western Canada: predominance of 14d subtypes.

机译:加拿大西部的梅毒螺旋体菌株的分子分型:14d亚型占优势。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Resurgence of syphilis in Canada and worldwide requires laboratories to update their methods for molecular epidemiology investigation and surveillance. This study utilizes polymerase chain reaction diagnostic tests for syphilis, identifies macrolide resistance, and uses a molecular typing system to characterize Treponema pallidum clinical strains causing syphilis in Alberta and Northwest Territories, Canada. METHODS: In total 449 specimens including genital swabs, whole blood, sera, and cerebrospinal fluid were obtained from 374 patients with suspect syphilis in Alberta and Northwest Territories. Molecular subtyping was based on genetic characterization of treponemal repeat genes, arp and tpr. Detection of macrolide resistance was accomplished by identification of the 23S rRNA gene mutation associated with the resistance pattern. RESULTS: Forty-nine specimens obtained from 43 patients were found to be positive for T. pallidum DNA using bmp, tpp47 and polA polymerase chain reaction assays. Four molecular subtypes were identified, with one type, 14d, accounting for 70% of all cases and 83% of typeable strains. Seven patients (16%) were found to be infected by macrolide-resistant strains, of which 6 were men who have sex with men and 1 whose infection was acquired in China. CONCLUSIONS: A single molecular type of T. pallidum, characterized as 14d, caused the majority of the syphilis cases identified in this study. A more discriminatory typing method would be required to determine if these strains are clonal. Treatment of infectious syphilis with macrolide antibiotics should be restricted to patient populations where resistance is rare and clinical and serological follow up of patients is possible.
机译:背景:梅毒在加拿大和世界范围内再次流行,要求实验室更新其分子流行病学调查和监测方法。这项研究利用梅毒的聚合酶链反应诊断测试,鉴定大环内酯类药物的耐药性,并使用分子分型系统对加拿大艾伯塔省和西北地区引起梅毒的梅毒螺旋体临床菌株进行表征。方法:从艾伯塔省和西北地区的374例梅毒可疑患者中获得了449份标本,包括生殖器拭子,全血,血清和脑脊液。分子亚型是基于端粒重复基因arp和tpr的遗传特征。大环内酯类药物耐药性的检测是通过鉴定与耐药模式相关的23S rRNA基因突变来完成的。结果:通过bmp,tpp47和polA聚合酶链反应分析,从43例患者中获得的49份标本被检出为梅毒螺旋体DNA阳性。确定了四种分子亚型,一种为14d,占所有病例的70%和可分型菌株的83%。发现有7名患者(占16%)感染了大环内酯类耐药菌株,其中6名与男性发生性关系的男性和1名在中国获得感染的男性。结论:以梅毒螺旋体为第14d的单一分子类型引起了本研究中确定的大多数梅毒病例。需要一种更具区别性的分型方法来确定这些菌株是否是克隆的。大环内酯类抗生素对感染性梅毒的治疗应仅限于耐药性极少且可能对患者进行临床和血清学随访的患者人群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号